自发性脑出血的微创手术:高质量随机临床试验的荟萃分析
这项系统综述与荟萃分析纳入14项高质量随机临床试验、共3027例自发性脑出血患者,比较微创手术与药物或开颅手术。微创手术与更高的长期良好功能结局几率相关(OR 1.51),并与更低的长期死亡率(OR 0.72)和早期死亡率(OR 0.73)相关,再出血率相似。
要点
- 微创手术与长期良好功能结局(改良Rankin量表0-3分)的几率升高相关(OR 1.51,95%CI 1.25-1.82)。
- 微创手术与长期死亡率(OR 0.72,95%CI 0.57-0.90)和早期死亡率(OR 0.73,95%CI 0.56-0.95)的几率降低相关。
- 微创手术与再出血率相似(OR 1.10,95%CI 0.55-2.19),未达统计学显著。
核心结论
- 该荟萃分析提供了高质量临床试验证据,支持将微创手术作为脑出血管理的初始治疗策略。
研究设计与样本
- 系统综述与荟萃分析,检索Medline、Embase、Scopus和Cochrane Library自建库至2024年4月12日,纳入14项高质量随机临床试验(RCT),共3027例脑出血患者(微创手术组1475例,药物管理或开颅手术组1452例),其中男性1899例(62.7%)。
主要发现
- 微创手术组长期良好功能结局(改良Rankin量表0-3分)的几率高于对照(OR 1.51,95%CI 1.25-1.82)。
- 微创手术组长期死亡率的几率低于对照(OR 0.72,95%CI 0.57-0.90)。
- 微创手术组早期死亡率(30天内)的几率低于对照(OR 0.73,95%CI 0.56-0.95)。
- 微创手术组与对照组的再出血率相似(OR 1.10,95%CI 0.55-2.19),未达统计学显著。
- 微创手术的治疗效应在多项敏感性和亚组分析中一致,包括深部脑出血患者。
关键数值与推荐
- 纳入标准限制为高质量随机临床试验,确保在Cochrane偏倚风险工具(RoB2)任何领域均不被认为存在高偏倚风险。
- 主要结局为良好功能结局(改良Rankin量表0-3分)和90天以后死亡率;次要结局为30天内早期死亡率和再出血率。
- 采用随机效应模型合并比值比(OR)及95%置信区间(CI)。
临床怎么用
- 原文结论认为该荟萃分析提供高质量临床试验证据支持将微创手术作为脑出血管理的初始治疗策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Spontaneous intracerebral hemorrhage (ICH) poses high mortality and morbidity rates with limited evidence-based therapeutic approaches. We aimed to evaluate the current evidence for the role of minimally invasive surgery (MIS) in the management of ICH. METHODS: This systematic review and meta-analysis followed recommended guidelines and protocols. Medline, Embase, Scopus, and the Cochrane Library were searched from inception up to April 12, 2024. The inclusion was restricted to randomized clinical trials (RCTs) of high quality, ensuring they were not deemed to have a high risk of bias in any of the Cochrane risk of bias tool (RoB2) domains. Primary outcomes were good functional outcome (modified Rankin scale, 0-3) and mortality beyond 90 days. Secondary outcomes were early mortality within 30 days and rebleeding rates. We pooled odds ratios (ORs) with corresponding 95% confidence intervals (CIs) using random-effects models. RESULTS: Fourteen high-quality RCTs were included. There were 3,027 patients with ICH (1,475 randomized to MIS, and 1,452 randomized to medical management or craniotomy). Of included patients, 1,899 (62.7%) were males. MIS resulted in higher odds of achieving long-term good functional outcome (OR, 1.51 [95% CI, 1.25-1.82]), lower odds of long-term mortality (OR, 0.72 [95% CI, 0.57-0.90]) and lower odds of early mortality (OR, 0.73 [95% CI, 0.56-0.95]). Rebleeding rates were similar (OR, 1.10 [95% CI, 0.55-2.19]). The treatment effect of MIS was consistent across multiple sensitivity and subgroup analyses, including individuals with deep ICH. INTERPRETATION: This meta-analysis provides high-quality clinical trial evidence supporting the use of MIS as a primary treatment strategy in the management of ICH. ANN NEUROL 2025;97:185-194.
引用
- Alkhiri A, Alamri AF, Almaghrabi AA, et al. Minimally Invasive Surgery for Spontaneous Intracerebral Hemorrhage: Meta-Analysis of High-Quality Randomized Clinical Trials. Ann Neurol. 2024. PMID: 39479898. doi:10.1002/ana.27107
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。